{"id":68952,"date":"2026-03-03T07:29:50","date_gmt":"2026-03-03T07:29:50","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68952"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"semax","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/semax\/","title":{"rendered":"Semax"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es Semax?<\/h3>\n<p style=\"margin: 0;\"><strong>Semax<\/strong> is a synthetic heptapeptide based on the 4\u201310 fragment of adrenocorticotropic hormone (ACTH). Developed at the Institute of Molecular Genetics in Russia, it is a nootropic and neuroprotective peptide best known for potent <strong>elevaci\u00f3n de BDNF<\/strong> y <strong>administraci\u00f3n intranasal en el SNC<\/strong>. Approved in Russia as a stroke-recovery drug \u2014 not FDA-approved. Supplied in 5\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">80714-61-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>37<\/sub>H<sub>51<\/sub>N<sub>9<\/sub>O<sub>10<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">813.93 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (o seg\u00fan suministro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar dentro de ~30 d\u00edas. Proteger de la luz. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua bacteriost\u00e1tica (recomendada) o agua est\u00e9ril para periodos de uso m\u00e1s cortos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es Semax?<\/h2>\n<p><strong>Semax<\/strong> (Met-Glu-His-Phe-Pro-Gly-Pro, sequence MEHFPGP) is a synthetic seven-amino-acid peptide developed in the 1980s at the Russian Institute of Molecular Genetics by Mekhedov, Malyshev, and collaborators. It is a structural analog of the ACTH 4\u201310 fragment \u2014 the central biologically-active region of adrenocorticotropic hormone \u2014 modified with a C-terminal Pro-Gly-Pro sequence that extends half-life and improves CNS penetration. Semax is <strong>aprobado en la Federaci\u00f3n Rusa<\/strong> as a prescription medication for acute ischemic stroke and cognitive-disorder indications, sold under the trade names Semax and Semaks. It is not approved by the FDA, EMA, or other Western regulators, so Western users access it through specialist supply. Molecular weight approximately 813.9\u00a0Da. Supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. Semax is <strong>for clinical studies use only<\/strong> outside its approved jurisdiction. For mechanism, clinical history, and context, see our <a href=\"https:\/\/medsbase.com\/es\/semax-peptide-nootropic-guide\/\">Semax guide<\/a>. <\/p>\n<h2>Mecanismo de acci\u00f3n \u2014 BDNF, melanocortina y penetraci\u00f3n en el SNC<\/h2>\n<p>Semax&#8217;s pharmacology combines three features that make it unusually well-studied for a nootropic peptide:<\/p>\n<ul>\n<li><strong>elevaci\u00f3n de BDNF<\/strong> \u2014 the most consistent observation across the Semax literature is rapid upregulation of <strong>factor neurotr\u00f3fico derivado del cerebro (BDNF)<\/strong> en el hipocampo y la corteza. El BDNF es un regulador maestro de la plasticidad sin\u00e1ptica, la supervivencia neuronal y la consolidaci\u00f3n de la memoria a largo plazo; su elevaci\u00f3n es la base molecular propuesta para los efectos cognitivos y neuroprotectores observados.<\/li>\n<li><strong>Actividad relacionada con los receptores de melanocortina<\/strong> \u2014 dado que Semax se deriva de la ACTH 4\u201310, conserva una afinidad de uni\u00f3n modesta para MC3R y MC4R. Esta actividad de los receptores de melanocortina es distinta de los efectos perif\u00e9ricos relacionados con el bronceado de an\u00e1logos m\u00e1s amplios de MC, como <a href=\"https:\/\/medsbase.com\/es\/melanotan-ii\/\">Melanotan II<\/a> porque Semax act\u00faa centralmente y no activa significativamente el MC1R.<\/li>\n<li><strong>Administraci\u00f3n intranasal en el SNC<\/strong> \u2014 Semax fue dise\u00f1ado espec\u00edficamente para la administraci\u00f3n <strong>nariz-cerebro.<\/strong> administration. Intranasal delivery bypasses the blood-brain barrier via olfactory-epithelial and trigeminal pathways, producing rapid CNS exposure within minutes. This is the primary administration route and is how the approved Russian products are administered.<\/li>\n<\/ul>\n<p>Additional reported mechanisms include attenuation of oxidative stress in neuronal study models, modulation of enkephalin and monoamine pathways, and effects on attention-related dopaminergic signaling \u2014 the combination that underpins ADHD-relevant contexts. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Semax is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Cognitive studies<\/strong> \u2014 memory, attention, and executive-function studies in rodent behavioral models (Dolotov et al., J Neurochem 2006)<\/li>\n<li><strong>Stroke recovery<\/strong> \u2014 modelos de ictus isqu\u00e9mico en roedores; Semax tiene aprobaci\u00f3n humana en Rusia para esta indicaci\u00f3n<\/li>\n<li><strong>ADHD studies<\/strong> \u2014 modelos de comportamiento de roedores con atenci\u00f3n\/hiperactividad<\/li>\n<li><strong>Neuroprotecci\u00f3n<\/strong> \u2014 oxidative-stress, glutamate toxicity, and neuronal-survival studies in aging models<\/li>\n<li><strong>Mood studies<\/strong> \u2014 anxiety and depression behavioral studies in rodent models<\/li>\n<li><strong>BDNF signaling studies<\/strong> \u2014 Semax is one of the most consistent peptide-based BDNF elevators available for preclinical studies (Kaplan et al., Neurosci Biobehav Rev 2022)<\/li>\n<li><strong>Stacking studies<\/strong> \u2014 frecuentemente combinado con <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD+<\/a> y <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> in longevity \/ cognitive protocols<\/li>\n<\/ul>\n<p>Para un contexto m\u00e1s amplio sobre p\u00e9ptidos nootr\u00f3picos y de longevidad, consulte <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a>. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase ofrece Semax en los siguientes tama\u00f1os de viales liofilizados:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilot dosing, short protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~33 administrations at 300 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Semax can be administered either intranasally (the primary administration route) or subcutaneously as an SC-reference dosing arm. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Comparativa \u2014 Semax frente a otros p\u00e9ptidos cognitivos\/de longevidad<\/h2>\n<p>Semax sits within a small group of nootropic and longevity peptides with published preclinical studies. Each uses a distinct mechanism:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Semax<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epital\u00f3n<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Elevaci\u00f3n del BDNF, relacionado con MC<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Se\u00f1alizaci\u00f3n de telomerasa\/pineal<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzima sirtuina\/PARP<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Recuperaci\u00f3n cognitiva y de accidente cerebrovascular<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Longitud de los tel\u00f3meros, ritmo circadiano<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Energ\u00eda celular, longevidad<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>V\u00eda principal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Intranasal (tambi\u00e9n SC)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Subcut\u00e1neo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">SC, IM o IV<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosis t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013600 mcg intranasal diarios<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg SC diarios<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013100 mg SC\/IM diarios<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Regulatorio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aprobado en Rusia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No aprobado<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No aprobado<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Users often study Semax together with <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> y <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD+<\/a> in longevity \/ neurocognitive-aging protocols because their mechanisms are complementary. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original, estables hasta 36 meses. Evite los ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> for intranasal studies, reconstitute at a concentration matched to a nasal dropper or spray. For SC-reference dosing, follow the chart above. Swirl gently \u2014 do <strong>ajuste<\/strong> sacuda \u2014 y permita 5\u201310 minutos para una disoluci\u00f3n completa. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> Conservar refrigerado a 2\u20138\u00a0\u00b0C y utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is Semax used for in studies?<\/h3>\n<p>Semax is used in studies investigating cognitive function, memory, attention, stroke recovery, ADHD-relevant pathways, neuroprotection, mood \/ anxiety studies, and BDNF signaling. It is approved in Russia for ischemic-stroke treatment; in the US and EU it is <strong>ajuste<\/strong> FDA\/EMA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>How is Semax administered in studies?<\/h3>\n<p>The primary administration route is <strong>intranasal<\/strong>, coincidiendo con el formato de administraci\u00f3n del producto aprobado en Rusia. La administraci\u00f3n nariz-cerebro atraviesa la barrera hematoencef\u00e1lica a trav\u00e9s de las v\u00edas olfativas y produce una exposici\u00f3n r\u00e1pida en el SNC. Algunos protocolos utilizan la inyecci\u00f3n subcut\u00e1nea como v\u00eda de dosificaci\u00f3n de referencia. La administraci\u00f3n oral no es efectiva porque Semax se degrada r\u00e1pidamente por las enzimas g\u00e1stricas. <\/p>\n<h3>What is the typical Semax dose?<\/h3>\n<p>Published preclinical and Russian-approved protocols typically use 250\u2013600\u00a0mcg intranasally, 1\u20133 times daily. Some protocols use SC 100\u2013300\u00a0mcg equivalent. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5.0\u00a0mg\/mL \u2014 6 ticks on a U-100 SC syringe delivers 300\u00a0mcg. <\/p>\n<h3>\u00bfEst\u00e1 Semax aprobado por la FDA?<\/h3>\n<p>No. Semax est\u00e1 aprobado en la Federaci\u00f3n Rusa para el tratamiento del ictus isqu\u00e9mico agudo y las indicaciones de trastornos cognitivos, pero no ha <strong>ajuste<\/strong> been approved by the FDA, EMA, MHRA, or any other Western regulator. <\/p>\n<h3>\u00bfQu\u00e9 efecto tiene Semax sobre el BDNF?<\/h3>\n<p>Published studies consistently shows rapid and sustained upregulation of brain-derived neurotrophic factor (BDNF) expression in hippocampus and cortex following Semax administration. BDNF is a master regulator of synaptic plasticity and long-term memory consolidation, and its elevation is the proposed mechanistic basis for the cognitive and neuroprotective studies observations. <\/p>\n<h3>\u00bfC\u00f3mo se debe almacenar Semax?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138\u00a0\u00b0C en el envase original, estable hasta 36 meses. Soluci\u00f3n reconstituida: refrigerada a 2\u20138\u00a0\u00b0C, utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h3>How do I reconstitute Semax for intranasal studies?<\/h3>\n<p>For nasal delivery, reconstitute at a concentration matched to your nasal dropper or spray delivery volume. A 10\u00a0mg vial in 2\u00a0mL gives 5\u00a0mg\/mL; a typical 50\u2013100\u00a0mcL nasal spray volume then delivers 250\u2013500\u00a0mcg per administration. Study protocols should target the specific per-spray volume of the delivery device used. <\/p>\n<h3>Can Semax be stacked with other peptides in studies?<\/h3>\n<p>S\u00ed. El Semax se combina com\u00fanmente con <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> y <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD+<\/a> in longevity and cognitive-aging protocols. The mechanisms are complementary \u2014 BDNF-driven neurotrophic signaling (Semax), telomere \/ circadian (Epitalon), cellular-energy \/ sirtuins (NAD+). <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase ofrece Semax en viales liofilizados de 5 mg y 10 mg. Cada concentraci\u00f3n est\u00e1 disponible en paquetes de 10, 20 o 30 viales. Todos los viales tienen una pureza HPLC de 99%+ y se incluye certificado de an\u00e1lisis bajo solicitud. <\/p>\n<h3>Does Semax cause side reported effects?<\/h3>\n<p>Published preclinical studies and Russian clinical-trial data report a clean safety profile. Minor transient nasal irritation after intranasal administration is the most commonly reported observation. No significant systemic side effects have been identified at standard doses. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media del Semax?<\/h3>\n<p>Semax has a short plasma half-life of approximately 2\u20133 minutes when administered intranasally or subcutaneously, attributed to rapid proteolytic degradation. Despite rapid systemic clearance, Semax demonstrates prolonged cognitive effects in preclinical studies \u2014 estimated at 20\u201324 hours \u2014 due to sustained BDNF upregulation in the brain rather than direct receptor occupation. <\/p>\n<h3>How does Semax compare to Selank in studies?<\/h3>\n<p>Semax and Selank are both synthetic nootropic peptides with Russian origins, but with distinct pharmacological profiles. Semax activates the BDNF\/TrkB pathway and shows stronger stimulatory and cognitive-enhancing effects in preclinical studies. Selank is derived from the immunomodulatory peptide tuftsin and has more pronounced anxiolytic properties. Studies stacks sometimes combine both for complementary cognitive and anxiolytic effects. <\/p>\n<h3>\u00bfPuedo pedir Semax para env\u00edo internacional?<\/h3>\n<p>S\u00ed. MedsBase env\u00eda Semax a todo el mundo desde nuestra red log\u00edstica especializada en p\u00e9ptidos. Los pedidos que solo contengan p\u00e9ptidos califican para nuestro servicio de env\u00edo exclusivo. Los env\u00edos se realizan en embalaje termorregulado con seguimiento completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/es\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/es\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpio sin cortisol\/prolactina<\/li>\n<li><a href=\"\/es\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH con vida media extendida<\/li>\n<li><a href=\"\/es\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lee nuestra gu\u00eda completa basada en evidencia: <a href=\"https:\/\/medsbase.com\/es\/semax-peptide-nootropic-guide\/\"><strong>Semax \u2014 mechanism, Russian clinical history, and honest studies<\/strong><\/a>. Covers BDNF pharmacology, ACTH 4-10 origin, intranasal delivery protocols, dosing ranges, and comparative nootropic context.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorece la resiliencia neuronal<br \/>\n\u2705 Mejora las v\u00edas cognitivas<br \/>\n\u2705 Modula la actividad de los neurotransmisores<br \/>\n\u2705 Promueve los factores neurotr\u00f3ficos<br \/>\n\u2705 Estabiliza los marcadores de respuesta al estr\u00e9s<\/p>\n<p><strong>Semax<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70979,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5467,5468,5466],"class_list":["post-68952","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-acth-4-7","product_tag-pro-gly-pro","product_tag-semax","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/68952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=68952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70979"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=68952"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=68952"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=68952"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=68952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}